Latest News & Features
Americas
Pfizer announced yesterday that it will launch a biosimilar of one of Johnson & Johnson’s (J&J) best-selling drugs, Remicade (infliximab), which brought in a total of $9.2 billion in revenue last year. 18 October 2016
Americas
David Manspeizer and Greg Chopskie have joined Morrison & Foerster’s intellectual property litigation practice group in its New York and Washington offices respectively. 18 October 2016
Big Pharma
The Court of Justice of the European Union has ruled that certain legislation on supplementary protection certificates applies to SPCs granted by a country before it has joined the EU. 17 October 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s patent ruling in favour of global pharma company Endo and Scotland-based Strakan International in a case against Actavis. 17 October 2016
Americas
Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar tablets. 14 October 2016
Americas
The Massachusetts Institute of Technology has succeeded in a patent infringement case against Shire Pharmaceuticals. 14 October 2016
Big Pharma
Pfizer has lost a battle against Actavis in a second medical use patent case centring on the drug Lyrica. 13 October 2016
Big Pharma
The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence. 13 October 2016
Americas
The US Food and Drug Administration has released a final rule to reduce unnecessary litigation between brand owners and generic drugs producers. 12 October 2016
Asia
India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash. 12 October 2016